There was a trend toward lower 60‐day survival free of rehospitalization in patients with lower urine sodium randomized to nesiritide compared with placebo that did not reach statistical significance ( P interaction of .06 unadjusted, .053 adjusted for eGFR, and furosemide‐equivalent dose).
← all excerpts
Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.
1
—
—